Evaluation of Biochemical Parameters of COVID 19 Patients as Biomarkers.

Objective: Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) has caused a global pandemic with more than 664 million confirmed cases and more than 6.7 million deaths worldwide. In pandemic, several studies have been done about the relationship of some biochemical and hematological parameters with COVID 19 in order to assist diagnosis and treatment. However, a lot of information is not completely complete and there are contradictions in the data. In the present study, it was focused to compare the biochemical parameters of patients and healthy individuals due to COVID 19 by investigating the relationship between age and gender. Methods: The 317 individuals who consulted to the Pandemic Outpatient Clinic with the suspicion of COVID 19 between February 2022 and November 2022 were evaluated by laboratory tests. In present study, biochemical parameter values of individuals with positive and negative COVID 19 test outcomes were used as material. These biochemical parameters were compared statistically based on different age ranges and gender groups. Results: It was ascertained that the values such as urea (UREA), creatine (KREA), ferritin (FER), aspartate transaminase (AST), alanine transaminase (ALT), high sensitivity troponin I (HSTI), creatine kinase (CK) and C reactive protein (CRP) in male patients with COVID 19 were higher than female patients with COVID 19. Moreover, it was detected that there was a statistically significant increase in parameters such as GLU, FER, AST, lactate dehydrogenase (LDH), HSTI, CK and CRP in COVID 19 patients aged 18-65 years. Conclusions: Many biomarkers of prognostic importance are expensive, ordinary and pricey-effective biomarkers such as FER, AST, LDH, HSTI, CK and CRP can be used to monitor disease in patients with COVID 19 infection. [ABSTRACT FROM AUTHOR]